down arrow

Fresenius Medical Care AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0005785802
  • ETR: FME
EUR
39.55
-0.13 (-0.33%)

Oct 02

ETR

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
4,860.57
4,612.15
5,070.00
4,884.85
4,791.71
4,881.45
5,085.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,860.57
4,612.15
5,070.00
4,884.85
4,791.71
4,881.45
5,085.00
Raw Material Cost
3,550.58
3,432.66
3,681.00
3,642.63
3,577.35
3,697.48
3,814.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
97.55
93.30
99.00
93.10
96.58
95.72
101.00
Selling and Distribution Expenses
730.06
639.90
772.02
706.40
778.77
738.92
754.95
Other Expenses
-5.79
-5.50
-6.00
-5.53
-5.85
-5.22
-5.10
Total Expenditure (Excl Depreciation)
4,320.27
4,110.86
4,492.02
4,386.78
4,394.24
4,479.88
4,618.94
Operating Profit (PBDIT) excl Other Income
540.3
501.3
578
498.1
397.5
401.59999999999997
466.1
Other Income
14.21
7.95
32.02
-37.46
16.22
0.76
15.54
Operating Profit (PBDIT)
911.66
863.13
983.00
818.83
775.72
784.93
958.60
Interest
97.55
93.30
99.00
93.10
96.58
95.72
101.00
Exceptional Items
-32.69
-249.74
-44.00
-11.62
-11.73
-103.80
-233.59
Gross Profit (PBDT)
1,309.98
1,179.49
1,389.00
1,242.22
1,214.36
1,183.98
1,271.00
Depreciation
357.16
353.90
373.00
358.21
362.03
382.60
477.00
Profit Before Tax
424.25
166.19
467.00
355.90
305.38
202.82
147.00
Tax
89.83
42.75
106.00
75.22
78.26
61.05
61.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
218.38
117.53
327.00
274.80
225.27
151.22
67.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
218.38
117.53
327.00
274.80
225.27
151.22
67.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
74.79
47.23
76.00
52.55
47.02
38.39
51.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
293.17
164.76
403.00
327.34
272.30
189.61
118.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
12,556.71
13,241.81
13,309.83
12,948.80
13,270.91
14,372.27
14,576.56
Earnings per share (EPS)
0.81
0.43
1.14
0.94
0.77
0.52
0.23
Diluted Earnings per share
0.81
0.43
1.14
0.94
0.77
0.52
0.23
Operating Profit Margin (Excl OI)
11.12%
10.87%
11.4%
10.2%
8.29%
8.23%
9.17%
Gross Profit Margin
16.08%
11.28%
16.57%
14.62%
13.93%
11.99%
12.27%
PAT Margin
4.49%
2.55%
6.45%
5.63%
4.7%
3.1%
1.32%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 5.39% vs -9.03% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 77.91% vs -59.11% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 4.95% vs -10.07% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is 4.61% vs -5.76% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Fresenius Medical Care AG With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(EUR)
Change(%)
Net Sales
4,860.57
5,764.00
-903.43
-15.67%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,860.57
5,764.00
-903.43
-15.67%
Raw Material Cost
3,550.58
3,314.00
236.58
7.14%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
97.55
103.00
-5.45
-5.29%
Selling and Distribution Expenses
730.06
940.00
-209.94
-22.33%
Other Expenses
-5.79
38.50
-44.29
-115.04%
Total Expenditure (Excl Depreciation)
4,320.27
4,742.00
-421.73
-8.89%
Operating Profit (PBDIT) excl Other Income
540.29
1,022.00
-481.71
-47.13%
Other Income
14.21
27.00
-12.79
-47.37%
Operating Profit (PBDIT)
911.66
1,354.00
-442.34
-32.67%
Interest
97.55
103.00
-5.45
-5.29%
Exceptional Items
-32.69
-68.00
35.31
51.93%
Gross Profit (PBDT)
1,309.98
2,450.00
-1,140.02
-46.53%
Depreciation
357.16
305.00
52.16
17.10%
Profit Before Tax
424.25
876.00
-451.75
-51.57%
Tax
89.83
201.00
-111.17
-55.31%
Provisions and contingencies
0
0
0.00
Profit After Tax
218.38
669.00
-450.62
-67.36%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
218.38
669.00
-450.62
-67.36%
Share in Profit of Associates
0
0
0.00
Minority Interest
74.79
7.00
67.79
968.43%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
293.17
676.00
-382.83
-56.63%
Equity Capital
0
0
0.00
Face Value
1.00
1.00
0.00
Reserves
12,556.71
19,102.00
-6,545.29
-34.26%
Earnings per share (EPS)
0.81
0.60
0.21
35.00%
Diluted Earnings per share
0.81
0.60
0.21
35.00%
Operating Profit Margin (Excl OI)
11.12%
17.73%
0.00
-6.61%
Gross Profit Margin
16.08%
20.49%
0.00
-4.41%
PAT Margin
4.49%
11.61%
0.00
-7.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 486.06 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 5.39% vs -9.03% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1.44% vs 0.53% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 29.32 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 77.91% vs -59.11% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 7.68% vs 13.27% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 89.75 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 4.95% vs -10.07% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 18.17% vs 3.12% in Jun 2025

Quarterly - Interest
Interest 9.76 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 4.61% vs -5.76% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1.04% vs -6.30% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.12%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025

Footer loading